[Intratumoral administration of Bayer E 39 in bladder carcinoma].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D001749:Urinary Bladder Neoplasms
D000970:Antineoplastic Agents
BLADDER/neoplasms; CYTOTOXIC DRUGS/therapeutic use
Intratumorale Anwendung von Bayer E 39 bei Blasenkarzinomen.